Abstract
Cellular changes occurring in mouse lung following the administration of myomontanone (MM) were compared with those due to another 3-substituted furan compound, 3-(N-ethylcarbamoyloxymethyl)furan (ECMF). The i.p. administration of lethal doses of these furans resulted in two different forms of lung injury. ECMF was particularly oedemagenic; it resulted in early damage to endothelial cells lining the alveolar capillaries and it also damaged the Clara cells of the terminal bronchioli. Myomontanone was much less oedemagenic and, initially, resulted in minimal cell damage. These minor changes were, however, followed by a delayed but acute injury to the type I pneumocytes, which progressed to elicit the proliferation of type II cells. These two forms of injury probably reflect significant differences in the mechanism of toxicity of the two compounds. The changes following dosing with ECMF resemble those reported after the administration of many other furans, e.g. 4-ipomeanol. The selective injury to type I pneumocytes, observed after MM, has been reported after the administration of many, apparently unrelated, compounds. The late development of MM-induced injury, long after the compound has presumably been cleared from the circulation, may result from the release of reactive metabolites which had previously been bound, reversibly, to cellular macromolecules.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adamson I. Y., Bowden D. H., Cote M. G., Witschi H. Lung injury induced by butylated hydroxytoluene: cytodynamic and biochemical studies in mice. Lab Invest. 1977 Jan;36(1):26–32. [PubMed] [Google Scholar]
- Boyd M. R. Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung. Nature. 1977 Oct 20;269(5630):713–715. doi: 10.1038/269713a0. [DOI] [PubMed] [Google Scholar]
- Butler W. H., Mattocks A. R., Barnes J. M. Lesions in the liver and lungs of rats given pyrrole derivatives of pyrrolizidine alkaloids. J Pathol. 1970 Mar;100(3):169–175. doi: 10.1002/path.1711000305. [DOI] [PubMed] [Google Scholar]
- Dinsdale D., Verschoyle R. D., Ingham J. E. Ultrastructural changes in rat Clara cells induced by a single dose of O,S,S-trimethyl phosphorodithioate. Arch Toxicol. 1984 Nov;56(1):59–65. doi: 10.1007/BF00316355. [DOI] [PubMed] [Google Scholar]
- Kehrer J. P., Kacew S. Systematically applied chemicals that damage lung tissue. Toxicology. 1985 Jun 28;35(4):251–293. doi: 10.1016/0300-483x(85)90062-9. [DOI] [PubMed] [Google Scholar]
- Larsson P., Tjälve H. Tracing tissues with 4-ipomeanol-metabolizing capacity in rats. Chem Biol Interact. 1988;67(1-2):1–24. doi: 10.1016/0009-2797(88)90082-8. [DOI] [PubMed] [Google Scholar]
- Mattocks A. R. Toxicity of pyrrolizidine alkaloids. Nature. 1968 Feb 24;217(5130):723–728. doi: 10.1038/217723a0. [DOI] [PubMed] [Google Scholar]
- Meyrick B., Miller J., Reid L. Pulmonary oedema induced by ANTU, or by high or low oxygen concentrations in rat--an electron microscopic study. Br J Exp Pathol. 1972 Aug;53(4):347–358. [PMC free article] [PubMed] [Google Scholar]
- Minty B. D., Scudder C. M., Grantham C. J., Jones J. G., Bakhle Y. S. Sequential changes in lung metabolism, permeability, and edema after ANTU. J Appl Physiol (1985) 1987 Feb;62(2):491–496. doi: 10.1152/jappl.1987.62.2.491. [DOI] [PubMed] [Google Scholar]
- Seawright A. A., Mattocks A. R. The toxicity of two synthetic 3-substituted furan carbamates. Experientia. 1973 Oct 15;29(10):1197–1200. doi: 10.1007/BF01935068. [DOI] [PubMed] [Google Scholar]
- Smith L. J. Lung damage induced by butylated hydroxytoluene in mice. Biochemical, cellular, and morphologic characterization. Am Rev Respir Dis. 1984 Nov;130(5):895–904. doi: 10.1164/arrd.1984.130.5.895. [DOI] [PubMed] [Google Scholar]
- Staub N. C. Pulmonary edema. Physiol Rev. 1974 Jul;54(3):678–811. doi: 10.1152/physrev.1974.54.3.678. [DOI] [PubMed] [Google Scholar]